Literature DB >> 7131028

Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage.

A R Wattendorff, G T Bots, L N Went, L J Endtz.   

Abstract

Eleven patients belonging to two generations of a Dutch family with cerebral and cerebellar haemorrhage, haemorrhagic infarction and infarction are described. Their ages varied from 44 to 58 years. The principal clinical characteristics was recurring cerebral haemorrhages, sometimes preceded by a history of migrainous headaches or mental changes. In 4 of the 6 autopsied cases, old and new multiple cerebral haemorrhagic infarcts and infarcts were found, in one case a single cerebral haemorrhage and in another a cerebellar haemorrhage. In 5 cases this resulted in secondary subarachnoid haemorrhage. In one case the infarcts were only slightly haemorrhagic and did not result in subarachnoid haemorrhage. This patient presented as dementia. Microscopically, in these 6 cases and in one biopsy specimen hyaline thickening of the walls of cortical arterioles was found. The arteries of the arachnoid showed marked tortuosity, concentric proliferation, and focal hyalinization of the walls. Amyloid was found in the hyalinized vessels in 5 cases, but not outside the central nervous system. We believe that we are dealing with an inherited disorder with an autosomal dominated mode of inheritance, in which microangiopathy leads to cerebral haemorrhage and (haemorrhagic) infarction. It seems likely that amyloidosis underlies the angiopathy, and that this family suffers from a condition similar to the one described by Gudmundsson in 1972.

Entities:  

Mesh:

Year:  1982        PMID: 7131028     DOI: 10.1016/0022-510x(82)90094-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  21 in total

Review 1.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

2.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.

Authors:  H V Vinters; G S Nishimura; D L Secor; W M Pardridge
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Gene mutations in inherited amyloidopathies of the nervous system.

Authors:  R E Tanzi
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

4.  Nonspecific dementia, cortical blindness, and Congophilic angiopathy. A clinicopathological report.

Authors:  S E Nadeau; J Bebin; E Smith
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

5.  Congophilic angiopathy with cerebrospinal symptoms.

Authors:  W Oelenberg; F Verspohl; R Menne; M Kutzner
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

6.  Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.

Authors:  F Coria; E M Castaño; B Frangione
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

7.  Sporadic cerebral amyloid angiopathy with giant cell reaction.

Authors:  J M Powers; B M Stein; R A Torres
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 8.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

Authors:  S G van Duinen; E M Castaño; F Prelli; G T Bots; W Luyendijk; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

Authors:  J Ghiso; O Jensson; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.